Vibrio cholerae non-O1の多剤排出ポンプの遺伝子クローニングと生化学的解析 by Md., Mushfequr Rahman



















Molecular cloning and biochemical characterization of the multidrug efflux 
pumps in Vibrio cholerae non-O1 
（Vibrio cholerae non-O1 の多剤排出ポンプの遺伝子クローニングと生
化学的解析） 
教授 土屋 友房  教授 森山 芳則  教授 三好 伸一 
 
学位論文内容の要旨 
Antibiotic resistant strains of Vibrio cholerae have repeatedly caused epidemics cholera, and 
drug resistant strains became a serious threat to the treatment of cholera patients. Among the several drug 
resistance mechanisms, multidrug efflux pumps play the major role in drug resistance in bacteria. So far 
some multidrug efflux pumps have been reported both from toxigenic and non-toxigenic V. cholerae. In 
order to exploit effective antimicrobial compounds to fight against V. cholerae and protect human health, 
as the first step, it is urgent and essential to understand the drug efflux mechanisms (protein) and the 
biochemical characterization of these efflux proteins. Thus, we decided to analyze the multidrug efflux 
transporters encoded by the V. cholerae which may be potentially involved in antibiotic extrusion.   
Through the isolation and characterization, I found three putative multidrug efflux transporters, 
namely VexAB, VexCD and VexEF from V. cholerae non-O1 NCTC 4716. All of them are the member of 
RND family, are capable of conferring increased MIC for the structurally and functionally unrelated 
compounds such as erythromycin, novobiocin, rhodamine 6G, TPPCl, cholates and so on. We previously 
reported Na+-dependent substrate efflux MATE family transporters from Vibrios. Interestingly, here I 
found one of the RND efflux pump, VexEF is a Na+-dependent efflux transporter. This is the first case of 
Na+-dependency in the RND-type efflux transporters.  
The role of bacterial MFS transporters in conferring drug resistance has been described from 
many bacteria. In V. cholerae, almost 40% of the putative multidrug efflux transporters belong to MFS 
family. Although there are some multidrug transporter have been reported form V. cholerae but so far 
only one multidrug efflux transporter of MFS family has characterized in V. cholerae. Out of eleven, I 
could succeed to clone six MFS genes from V. cholerae non-O1 and tried to characterize them in E. coli 
but did not get any drug resistance activity. There might have some reason for that. Therefore, further 
studies are needed for these putative pump genes. 
Despite extensive research for many years, the actual mechanism of multidrug transport is still 
largely unknown.  Further, the existence of antibiotic efflux pumps and their impact on therapy must 
now be taken fully into account for the selection of novel antimicrobials. The design of specific, potent 













vexCD, vexEF, vexGH, vexIJK, vexLKのV. cholerae non-O1細胞での発現も調べている。実際に
これら遺伝子の発現が確認されたことから、これらの多剤排出ポンプは実際にこの菌の多
剤耐性に関わっているものと思われた。 
 以上のように、この論文は V. cholerae non-O1 の多剤耐性に関わる RND 型多剤排出ポンプ
の６個の遺伝子クローニングと性質の解析を行った大変興味深いものであり、博士（学術）
の学位に値するものと判断した。
